CN Stock MarketDetailed Quotes

Yunnan Botanee Bio-Technology Group (300957)

Watchlist
  • 34.05
  • +1.11+3.37%
Market Closed Jun 12 15:00 CST
14.42BMarket Cap26.54P/E (TTM)

About Yunnan Botanee Bio-Technology Group Company

Founded in 2010, the company is a comprehensive health-care group that integrates R&D, manufacturing, and marketing, with a strategic focus on the "Internet Plus" model for skin health. It is committed to building a thriving Chinese ecosystem for skin health and advancing the country's broader health-care industry. On March 25, 2021, the company was listed on the ChiNext Board of the Shenzhen Stock Exchange. Its core business encompasses the R&D, production, and sales of cosmetics. The product portfolio includes skincare items such as facial creams, toners, masks, serums, and lotions, as well as color cosmetics like primers, pressed powders, BB creams, and cleansing waters. The company has received numerous accolades, including the Yunnan Provincial Engineering Research Center for Functional Skincare Products, the Yunnan Provincial Specialized, Sophisticated, and Novel "Little Giant" designation, the Yunnan Provincial May Day Labor Award, the National Demonstration Enterprise for Green Supply Chain Management, the National Industrial Design Center, the National Model Enterprise for Technological Innovation, the Yunnan Provincial People's Government Quality Award, the title of "National Industrial Design Center," the China Consumer Brand Award, the "Best Listed Company of 2024," the "Best Practice in Investor Relations Management among Listed Companies for 2024," the highest AAA ESG rating from Huazheng ESG and the AA ESG certification from Wind—both recognized as industry-leading achievements, the First Prize of the China Light Industry Federation Science and Technology Progress Award, inclusion among the Top Ten Enterprises in China's Light Industry Cosmetics Sector, and the Top 100 Innovative Enterprises in China's Light Industry.

Company Profile

Short Name-A贝泰妮
Symbol-A300957
Company NameYunnan Botanee Bio-Technology Group Co. LTD
Listing DateMar 25, 2021
Issue Price47.33
Shares Offered63.60M share(s)
FoundedMay 13, 2010
Legal Representativezhenyu guo
General Managerzhenyu guo
Secretarylong wang
Accounting FirmTianheng Certified Public Accountants (Special General Partnership)
Securities Representativeminjing xu
Legal CounselJunhe Law Firm, Beijing
Employees510
Phone021-62321125
Office AddressNo. 53, Keyi Road, High-tech Industrial Development Zone, Kunming City, Yunnan Province
Zip Code650106
Registered AddressNo. 53, Keyi Road, High-tech Industrial Development Zone, Kunming City, Yunnan Province
Fax021-62321125
Emailir@botanee.com
Business License

530102100098658

Business

General Items: Research and development and application of cell technologies; technical services, technological development, technical consulting, technology exchange, technology transfer, and technology promotion; retail sale of cosmetics; wholesale of cosmetics; sale of daily necessities; import and export of technology; import and export of goods; production of protective equipment for medical personnel (Class I medical devices); research and development of biochemical products; manufacturing of daily chemical products; sale of daily chemical products; production of Class I medical devices; sale of Class I medical devices; sale of Class II medical devices; sale of disinfectants (excluding hazardous chemicals); sale of health food (pre-packaged). (Except for items that, according to law, require approval, business activities may be conducted independently in accordance with the business license.) Licensed Items: Production of cosmetics; production of Class II medical devices; production of Class III medical devices; operation of Class III medical devices; production of disinfectants (excluding hazardous chemicals); sale of food; online sale of food. (For items that, according to law, require approval, business activities may be carried out only upon approval by the relevant authorities; the specific scope of business shall be subject to the approval documents or licenses issued by the relevant authorities.)

Company Executives

  • Name
  • Position
  • Salary
  • zhenyu guo
  • Chairman, Director, General Manager, Chairperson of the Strategic Committee, Member of the Compensation and Assessment Committee
  • 4.90M
  • KEVIN GUO
  • Director
  • 480.00K
  • wei zhou
  • Director
  • 600.00K
  • xiao ma
  • Director, Senior Deputy General Manager, Member of the Nomination Committee, Member of the Strategic Committee
  • 4.00M
  • shaoyang gao
  • Director, Senior Deputy General Manager, Member of the Strategic Committee
  • 3.47M
  • hule liu
  • Independent Director, Member of the Audit Committee, Member of the Compensation and Assessment Committee, Chair of the Nomination Committee
  • 125.80K
  • guozhong he
  • Independent Director, Member of the Audit Committee, Chair of the Compensation and Assessment Committee, Member of the Strategic Committee
  • 125.80K
  • ronghui yao
  • Independent Director, Member of the Nomination Committee, Member of the Strategic Committee, Chairperson of the Audit Committee
  • 200.00K
  • long wang
  • Board Secretary, Deputy General Manager, Chief Financial Officer
  • 2.95M
  • minjing xu
  • Securities Affairs Representative
  • --
  • xiaojing wu
  • Deputy General Manager
  • 2.95M
  • mei zhang
  • Deputy General Manager, Employee Director
  • 3.00M
  • feifei wang
  • Deputy General Manager
  • 2.99M
  • chenghui bian
  • Deputy General Manager
  • 2.71M
  • xiting wang
  • Head of Internal Audit
  • --
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More